Sustainable Pharmaceutical Packaging Market

Updated on : October 10, 2024

Sustainable Pharmaceutical Packaging Market

The sustainable pharmaceutical packaging market was valued at USD 71.6 billion in 2022 and is projected to reach USD 146.3 billion by 2027, growing at 15.4% cagr from 2022 to 2027. The global market is growing due to the to stringent laws and regulations levied by governments and governing bodies, as well as a shift in consumer preferences towards recyclable and eco-friendly packaging materials.

Attractive Opportunities in Sustainable Pharmaceutical Packaging Market

Note:e-estimated,p-projected.

Source: Expert Interviews, Secondary Sources, and MarketsandMarkets Analysis

To know about the assumptions considered for the study, Request for Free Sample Report

Sustainable Pharmaceutical Packaging Market Dynamics

Driver:  Consumer preference towards recyclable and eco-friendly  materials

In recent years, there has been a shift in consumer preference toward more sustainable and eco-friendly materials in the packaging industry. This trend is driven by concerns about environmental pollution and the depletion of natural resources, as well as a growing awareness of the impacts of packaging waste on the planet. Consumers are increasingly looking for packaging made from recycled materials, such as paper, cardboard, and plastic. They are also interested in biodegradable and compostable options.

Restraint: Increase in packaging cost

Sustainability policies aimed at reducing waste and increasing recycling can lead to an increase in overall packaging costs. This is because sustainable packaging materials, such as biodegradable plastics or recycled materials, are often more expensive than traditional materials. The cost of packaging design, testing, and certification to meet sustainability standards can also add to the overall cost. Implementing recycling and recovery systems for used packaging materials can also be costly. These increased costs can be passed on to consumers through higher prices for products packaged in sustainable materials.

Opportunity: Growing demand  for primary pharmaceutical packaging.

Primary pharmaceutical packaging products such as plastic bottles, glass bottles, prefilled syringes, prefilled inhalers, medication tubes, and blister packaging, among others, come in direct contact with the medicine or drug. There is a surge in demand for sustainability in primary pharmaceutical packaging due to increasing consumer awareness of environmental issues, government regulations, and industry initiatives on environmentally friendly packaging. Industry initiatives have also played a role in promoting sustainable practices in primary pharmaceutical packaging.

Challenge: Fluctuation in prices of raw material

Fluctuations in raw material prices can have a significant impact on the sustainable pharmaceutical packaging industry. Sustainability in packaging often requires using alternative materials that are less common, more complex, or more expensive than traditional options. These materials are often more sensitive to price fluctuations.The cost of producing sustainable packaging increases when raw material prices increase, which can make it less competitive with traditional packaging options. This can make it difficult for sustainable packaging manufacturers to remain profitable and make sustainable packaging more expensive for consumers. This can cause a decrease in the demand for sustainable packaging and could lead to a slowdown in the growth of the industry.

Plastics segment amongst other raw material projected to grow at a highest CAGR from 2022 to 2027, in terms of volume

Plastics can be easily formed, possess high quality, are cost-effective, and provide excellent barrier properties and freedom of design. Plastic molded containers provide superior resistance to breakage and offer safety to consumers. The use of recyclable plastics in the sustainable pharmaceutical packaging industry is becoming increasingly important as companies and consumers become more aware of the impact of packaging materials. Recyclable plastics, such as PET and HDPE, can be used to create packaging that is not only environmentally friendly but also cost-effective and safe for the storage and transportation of pharmaceutical products

Biodegradable  segment projected to grow at highest cagr from 2022 to 2027, in terms of value

The use of biodegradable packaging in the pharmaceutical industry has the potential to reduce the environmental impact of packaging materials and conserve resources. Biodegradable plastics can be composed of bioplastics manufactured from renewable raw materials. There are usually two forms of biodegradable plastic, injection molded and solid. The solid forms are generally used for food containers, leaf collection bags, and water bottles. Such plastics do not decompose unless disposed of properly, meaning that biodegradable plastics must be treated to compost.

Asia Pacific is projected to grow the fastest in the sustainable pharmaceutical packaging market during the forecast period.

The Asia Pacific region has emerged as the fastest growing market for sustainable pharmaceutical packaging. This is due to the increasing focus on sustainability and environmental protection, coupled with the rapid growth of the pharmaceutical industry in the region. The pharmaceutical industry in Asia Pacific is growing rapidly due to the large population and increasing healthcare spending, and this has increased the demand for sustainable packaging solutions. Companies in the region are investing heavily in research and development to create new and innovative sustainable packaging solutions to meet the growing demand from consumers and healthcare providers. Additionally, governments in the region are implementing policies and regulations to promote sustainable packaging and reduce environmental impact, further driving the growth of the market.

To know about the assumptions considered for the study, download the pdf brochure

Sustainable Pharmaceutical Packaging Market Players

The key players in the sustaianble pharmaceutical packaging market include Schott AG (Germany), Amcor PLC (Switzerland), AptarGroup,Inc (US), West Pharmaceutical Services, Inc. (US), Berry Global (US), Gerresheimer AG (Germany), Catalent,Inc (US), and WestRock (US). The pharmaceutical packaging market report analyzes the key growth strategies, such as new product launches, investments & expansions, joint ventures, agreements, partnerships, and mergers & acquisitions adopted by the leading market players between 2019 and 2022.

Sustainable Pharmaceutical Packaging Market Report Scope

This research report categorizes the sustaianble pharmaceutical packaging market based on raw material, types, drug delivery modes, and region.

By Material:

• Plastics
• Paper & paperboard
• Glass
• Metal
• Others

By Packaging Type:

• Primary Packaging
• Secondary Packaging

By Product Type

• Plastic bottles
• Blister
• Labels & accessories
• Caps & closures
• Pre-filled syringes
• Medical specialty bags
• Temp controlled packaging
• Pouches & strip packs
• Pre-filled inhalers
• Vials
• Ampoules
• Medication tubes
• Jars & Canisters
• Cartriges
• Others

By Process:

• Recyclable
• Reusable
• Biodegradable

By Region:

• North America
• Aisa Pacific
• Europe
• Middle East & Africa
• South America

The pharmaceutical packaging market has been further analyzed based on key countries in each of these regions.

Recent Developments

• In September 2022, Aptar Pharma launched an innovative dispensing solution that is mono-material and fully recyclable when paired with a PE or PET bottle. It is suitable for a range of viscosities, customizable with two dosage options and two neck size options, and is available in a variety of colors with its unique, three-part design.
• In September 2022, Berry Global Group, Inc. announced a collaboration with Mars Inc. to launch its popular pantry-sized treats in polyethylene terephthalate (PET) jars that have been optimized by including 15% recycled plastic content, i.e., post-consumer resin (PCR).
•  In November 2022, Aptar Pharma announced its collaboration with TFF Pharmaceuticals. This collaboration is aimed at developing and testing the administration of dry powder vaccines utilizing TFF Pharmaceutical’s Thin Film Freezing technology and Aptar Pharma’s proprietary intranasal Unidose (UDS) powder nasal spray system.
• In June 2022, WestRock Company announced a partnership with Recipe Unlimited to introduce a line of recyclable paperboard packaging, with the goal of keeping 31 million plastic bottles out of Canada's landfills annually.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst